BlackRock Health Sciences Trust (BME)
NYSE: BME · Real-Time Price · USD
41.89
-0.03 (-0.07%)
Feb 11, 2026, 4:00 PM EST - Market closed

BME Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-26.0523.4520.02-26.4759.1279.56
Loss (Gain) From Sale of Investments
27.29-22.39-18.0128.05-59.12-79.42
Other Operating Activities
80.4363.9530.77-2.78-21.8-19.11
Change in Accounts Receivable
0.070.22-0.02-0.160.01-0.04
Change in Income Taxes
----0.010.01-
Change in Other Net Operating Assets
0.370.29-0.750.50.23-0.35
Operating Cash Flow
82.1165.5232.02-0.87-21.56-19.35
Operating Cash Flow Growth
129.79%104.63%----
Short-Term Debt Issued
--0.060--
Total Debt Issued
--0.060--
Short-Term Debt Repaid
--0.06----
Total Debt Repaid
--0.06----
Net Debt Issued (Repaid)
--0.060.060--
Issuance of Common Stock
--3.0233.6250.3345.09
Repurchase of Common Stock
-43.51-29.53----
Common Dividends Paid
-38.57-35.92-35.1-32.73-29-25.65
Other Financing Activities
---0-0.020.02-
Financing Cash Flow
-82.08-65.52-32.020.8821.3419.44
Foreign Exchange Rate Adjustments
0-0-00-0-
Net Cash Flow
0.040.01-00-0.210.09
Cash Interest Paid
000---
Levered Free Cash Flow
13.51-2.154.66-15.812.282.04
Unlevered Free Cash Flow
13.51-2.154.66-15.812.282.04
Change in Working Capital
0.450.51-0.770.330.25-0.39
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q